News from the Nodes
Northeast Node
 On Tuesday, May 30, 2017, the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network, together with the Center for Technology and Behavioral Health (CTBH) at the Geisel School of Medicine at Dartmouth, welcomed the Director of the National Institute on Drug Abuse (NIDA), Dr. Nora Volkow, and New Hampshire State Representative Ann McLane Kuster (D-NH2) to discuss New Hampshire’s opioid crisis.
"Tackling the New Hampshire Opioid Crisis: Harnessing the Power of Science to Break the Cycle" brought together Dr. Volkow, Congresswoman Kuster, CTBH and Northeast Node Director Lisa Marsch, and three innovative programs from the surrounding area to discuss the science behind New Hampshire’s opioid crisis and how the state might best move forward in breaking it.
Congresswoman Kuster, founder and co-chair of the House Bipartisan Heroin Task Force, gave her perspectives no the crisis from around the state and in Congress. She called for increased vigilance from Washington, particularly with the President's proposed 2018 budget and the role Medicaid plays in treating substance use disorders.
Dr. Marsch presented findings from the New Hampshire HotSpot study, funded by the National Drug Early Warning System and NIDA, conducted by the Northeast Node.
Dr. Volkow provided the keynote address, highlighting the state of the science on opioid use disorders and the problem in New Hampshire, which ranks second in highest drug poisoning death rates per capita.
The next day, leaders from CTBH and the Northeast Node accompanied Dr. Volkow on a tour of the Manchester community and its opioid crisis response teams, visiting Catholic Medical Center, Safe Station at the Manchester Fire Department, and Serenity Place. New Hampshire Senator Jeanne Shaheen joined in the tour and discussion at Catholic Medical Center.
Read more about the event here. . .
From the ATTC
From the ATTC/NIATx Service Improvement Blog:
Project ECHO LGBT: Making System Change to Address a High-Risk Population, by Kelly Gagnon of Weitzman Institute at Community Health Center, Inc. How can you effectively treat a high risk population without knowing which patients make up that population? The answer is: you can't. This initiative aimed to improve the quality of care LGBT patients received at 10 Federally Qualified Health Centers.
Honoring Pride Month 2017: YMSM + LGBT Webinar Series by Brandy T. Oeser, MPH, YMSM+LGBT ATTC Center of Excellence. This special two-part series presented 4 model programs serving young men who have sex with men (YMSM) of color.
ATTC Messenger June 2017: Addiction Medicine: Physician Certification in the New Sub-Specialty. In 2016, the American Board of Medical Specialties (ABMS) formally recognized Addiction Medicine as a new subspecialty under the American Board of Preventive Medicine.
|
Greater New York Node
 The Greater New York Node of NIDA’s Clinical Trials Network is hosting a half-day symposium, Harnessing Policy, Practice and Research to Address the Opioid Epidemic, the afternoon of Wednesday, September 13 at NYU’s Washington Square Kimmel Center.
Speakers are addiction experts from federal, state and local organizations and from academia. Our intended audience includes addiction professionals, leaders and staff from government agencies, private practice, hospitals and other healthcare facilities, and researchers and educators. Students are welcome.
Topics will include:
- a view of the opioid epidemic from NIDA,
- efforts in Massachusetts to address opioid use disorder (OUD) and the overdose epidemic,
- Vermont’s Care Alliance for OUD treatment,
- addressing the capacity/need gap for medication assisted treatment in New York,
- a public health approach to overdose and misuse, and
- how the nation’s largest public hospital system is responding to the crisis.
View the complete agenda here.
The event is free but space is limited and registration is required, PLEASE REGISTER HERE.
Health Systems Node
 The Health Systems Node is very pleased to inform the CTN community that sites have been selected for the PRimary care Opioid Use Disorders (PROUD) Treatment Trial, CTN-0074.
The six sites are: Harris Health System (Texas Node), Henry Ford Health System (Health Systems Node), Kaiser Permanente Washington (Health Systems Node), Montefiore Health System (Greater New York Node), MultiCare Health System (Pacific Northwest Node), and University of Miami Health System (Florida Node Alliance).
Kathy Bradley, MD, MPH, one of the Health System Node’s three MPIs (along with Cynthia Campbell, PhD, MPH and Connie Weisner, DrPH, LCSW) is leading PROUD.
PROUD is the HSN’s first opportunity to lead a pragmatic, cluster-randomized, quality improvement trial in the CTN, in which all outcome data will come from health systems’ electronic health records. The trial is assessing whether the Massachusetts Model, which uses a nurse care manager to support treatment of opioid use disorder (OUD) in primary care, is effective in large health systems.
As the HSN's first trial, the Node is incredibly appreciative of all the support they have received from the CCTN, the DSC, and the CCC; the 11 Site PIs and their teams who participated in Phase 1 of PROUD; the PROUD protocol development investigators; and their collaborators, who developed the Massachusetts Model at Boston Medical Center. They are looking forward to beginning the trial this fall. |
The Office of Disease Prevention and Health Promotion (ODPHP) and the Office of Minority Health (OMH) are pleased to announce the release of a new 
Addiction Health Services Research Pre-Conference Workshops, October 2017
National Cannabis Summit, August 28-20, 2017, Denver, Colorado
